Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral testosterone study of protein metabolism in healthy men
ACTRN12614001045606Phase 4Not yet recruiting
- Sponsor
- Garvan Institute of Medical Research
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of testosterone, sponsored by Garvan Institute of Medical Research. Primary endpoint: Protein turnover by stable isotopes. Planned start Oct 2014; status: not yet recruiting.
02
Drugs
testosterone
Beyond the preview
Go deeper on ACTRN12614001045606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614001045606.